Vito Lorusso

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

David Cunningham, István Láng, Eugenio Marcuello et al. · The Lancet Oncology · 2013 · 654 citations

Medicine, Oncology, Pharmacology +10

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study

Maurizio Muscaritoli, Simone Lucia, Alessio Farcomeni et al. · Oncotarget · 2017 · 424 citations · Full text

Agriculture, Nutrition, Oncology +17

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Matti Aapro, H. S. Rugo, Giada Rizzi et al. · Annals of Oncology · 2014 · 248 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

Alberto Spinazzi, Vito Lorusso, Gianpaolo Pirovano · Academic Radiology · 1999 · 203 citations

Medicine, Pharmacology, Radiology +13

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

M. De Lena, Vito Lorusso, Agnese Latorre et al. · European Journal of Cancer · 2001 · 169 citations

Medicine, Oncology, Pharmacology +14